ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.17X leverage
Performance
- Low
- ₹871
- High
- ₹893
- 52 Week Low
- ₹847
- 52 Week High
- ₹1,251
- Open Price₹877
- Previous Close₹877
- Volume38,697
- 50 DMA₹904.63
- 100 DMA₹924.59
- 200 DMA₹953.28
Investment Returns
- Over 1 Month -0.01%
- Over 3 Month -3.96%
- Over 6 Month -17.18%
- Over 1 Year -12.79%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.6
- PEG Ratio
- 0.8
- Market Cap Cr
- 10,902
- P/B Ratio
- 3.6
- Average True Range
- 23.06
- EPS
- 43.23
- Dividend Yield
- 0.6
- MACD Signal
- -0.57
- RSI
- 46.46
- MFI
- 30.85
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹888.60
+
11.9
(1.36%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹897.64
- 50 Day
- ₹904.63
- 100 Day
- ₹924.59
- 200 Day
- ₹953.28
Resistance and Support
884.42
- R3 919.13
- R2 906.17
- R1 897.38
- S1 875.63
- S2 862.67
- S3 853.88
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹888 As on 16 January, 2026 | 01:49
The Market Cap of Alivus Life Sciences is ₹10901.5 Cr As on 16 January, 2026 | 01:49
The P/E ratio of Alivus Life Sciences is 20.6 As on 16 January, 2026 | 01:49
The PB ratio of Alivus Life Sciences is 3.6 As on 16 January, 2026 | 01:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.